Request Demo
Last update 14 Jun 2025
SHR9549
Last update 14 Jun 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms SHR 9549, SHR-9549 |
Target |
Action antagonists |
Mechanism ERs antagonists(Estrogen receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
RegulationSpecial Review Project (China) |
Login to view timeline
Related
1
Clinical Trials associated with SHR9549NCT03596658
Phase I, Open-Label, Multicentre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumour Activity of Ascending Doses of SHR9549 in Women With ER Positive HER2 Negative Advanced Breast Cancer
100 Clinical Results associated with SHR9549
Login to view more data
100 Translational Medicine associated with SHR9549
Login to view more data
100 Patents (Medical) associated with SHR9549
Login to view more data
100 Deals associated with SHR9549
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| ER-positive/HER2-negative Breast Cancer | Phase 1 | China | 25 Jul 2018 | |
| Estrogen receptor positive breast cancer | Phase 1 | China | 25 Jul 2018 | |
| HER2-negative breast cancer | Phase 1 | China | 25 Jul 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free